• Info
  • Significant Ownership

Significant Ownership of Orca Capital AG

Signature - Title
/s/ Thomas Konig - Thomas Konig/Director
Location
Pfaffenhofen, Germany
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Orca Capital AG.

Notify me when Orca Capital AG files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Orca Capital AG

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SGN Signing Day Sports, Inc. Common Stock, par value $0.0001 per share 9.9% $1,522,460 1,409,685 Orca Capital AG 13 Jan 2026
ATON AlphaTON Capital Corp Ordinary Shares, no par value 9.9% $817,800 1,410,000 Orca Capital AG 13 Jan 2026
Chijet Motor Company, Inc. Ordinary Shares, par value US$0.003 9.9% 437,285 Orca Capital AG 24 Nov 2025
PHIO Phio Pharmaceuticals Corp. Common Stock, par value $0.0001 per share 4.9% $662,610 -$198,908 538,707 -23% Orca Capital AG 08 Dec 2025
PPBT Purple Biotech Ltd. American Depositary Shares, each representing 200 Ordinary Shares 4.9% $652,619 306,394 Orca Capital AG 04 Sep 2025
KTTA Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share 4.9% $515,257 -$11,765 362,857 -2.2% Orca Capital AG 07 May 2025
SXTP 60 Degrees Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.9% $397,287 166,229 Orca Capital AG 15 Jul 2025
VERO Venus Concept Inc. Common Stock, par value $0.001 per share 4.9% $253,353 +$253,353 101,748 Orca Capital AG 06 Jun 2025
ENVB Enveric Biosciences, Inc. Common Stock, par value $0.01 per share 4.9% $32,016 -$22,984 97,019 -42% Orca Capital AG 31 Jan 2025
Silexion Therapeutics Corp Ordinary Shares, par value $0.0135 per share 4.9% 109,432 Orca Capital AG 11 Sep 2025
LIXT Lixte Biotechnology Holdings, Inc. Common Stock, par value $0.0001 per share 4.5% $145,215 -$117,830 120,012 -45% Orca Capital AG 14 Feb 2025
RANI Rani Therapeutics Holdings, Inc. Class A Common Stock, par value $0.0001 per share 4.3% $907,979 -$1,181,941 1,891,623 -57% Orca Capital AG 22 Jul 2025
CANF Can-Fite BioPharma Ltd. Ordinary Shares, no par value 4.1% $220,335,780 -$304,664,220 157,382,700 -58% Orca Capital AG 22 Apr 2025
CODX Co-Diagnostics, Inc. Common Stock, par value $0.001 per share 3.7% $818,338 +$19,827 2,248,182 +2.5% Orca Capital AG 28 Oct 2025
DWTX Dogwood Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.7% $205,274 -$135,149 69,821 -40% Orca Capital AG 14 Mar 2025
SPCB SuperCom Ltd. Ordinary Shares, par value NIS 50 3.6% $741,269 -$881,457 124,583 -54% Orca Capital AG 31 Jan 2025
SGLY Singularity Future Technology Ltd. Common Stock, no par value 0% $0 -$170,334 0 -100% Orca Capital AG 31 Jan 2025
BHAT Blue Hat Interactive Entertainment Technology Ordinary Shares, par value $0.01 per share 0% $0 -$248,400 0 -100% Orca Capital AG 13 Jan 2025

Schedules 13D/G Reported by Orca Capital AG:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.